Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Everolimus
Related studies linked through entity extraction aliases.
Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype
- Status
- RECRUITING
- Phase
- PHASE3
Rapalog Pharmacology (RAP PAC) Study
- Status
- RECRUITING
- Phase
- PHASE1
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
- Status
- RECRUITING
- Phase
- PHASE3
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Status
- RECRUITING
- Phase
- PHASE2
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
- Status
- RECRUITING
- Phase
- PHASE2
Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Adjunctive Everolimus Treatment of Refractory Epilepsy
- Status
- UNKNOWN
- Phase
- PHASE2
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
- Status
- RECRUITING
- Phase
- PHASE3
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
- Status
- RECRUITING
- Phase
- PHASE3
Pilot Trial for Treatment of Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3